Central Laboratories Archives

Central Laboratories

Evaluating the Effect of Hemolysis, Icterus, and Lipemia on Chemistry Assays

December 19, 2018

Experts from Medpace’s central laboratory evaluated the effect of hemolysis, icterus and lipemia on chemistry assays and assessed the association between the amount of interfering substances and ordinal values reported by the automated chemistry analyzer as H-, I- and L-indices. They presented their findings at the 70th AACC Annual Scientific Meeting & Clinical Lab Expo in Chicago.

Central Laboratories

State of the Art Flow Cytometry Techniques Now Supported in Singapore

September 17, 2018

Medpace offers global flow cytometry capabilities, with flow cytometry departments located at our US, Belgium and Singapore central laboratories.

Central Laboratories

New Biomarker Assay Validations from Medpace’s Central Labs

September 12, 2018

With an already robust menu of validated assays, the increase in new biomarker assay validations speaks to the seamless service we provide to our Sponsors.

Central Laboratories

Medpace Expands Production Capabilities for Collection Kits

September 5, 2018

As part of our mission to deliver superb customer service and site support, we have recently expanded our kit building capabilities in the US and are currently expanding in the rest of the world.

Updates Regarding Medpace’s Biorepository Services

Central Laboratories

Medpace’s Biorepository Services: Expansion and Highlights

August 31, 2018

In this post, we highlight some of the key investments we have made in each of our biorepositories around the world and what that means for our Sponsors.

Central Laboratories

Molecular Capabilities and Genetic Laboratory Expansion

August 22, 2018

With the advancement of precision medicine, molecular and genetic testing is becoming a critical component for patient selection and individual assessment of the risks and benefits of treatment. Known for partnering with sponsors at a very high-level of scientific engagement, the expansion of our molecular suite (1,975 square feet) further enhances our ability to support sponsors with advanced testing to detect pathogenic events at the genome level.

Central Laboratories

Medpace Harmonizes Global Data across Its Regional Laboratories

October 17, 2017

Data from central laboratories have been key for assessing safety, tolerability, and efficacy of new drugs in clinical trials. With the increasing complexity and global scale of many clinical trials, it is important to maintain harmonization. Learn how we harmonize our data across our regional laboratories.

Central Laboratories

Biomarkers for Celiac Disease Clinical Trials

October 2, 2017

As a full service, global CRO with an integrated central lab, Medpace has the scientific, operational and regulatory expertise to manage your celiac disease clinical trial.